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HemolysisThe two novel cyanobacterial cyclic lipopeptides, anabaenolysin (Abl) A and B permeabilised mammalian
cells, leading to necrotic death. Abl A was a more potent haemolysin than other known biodetergents, includ-
ing digitonin, and induced discocyte–echinocyte transformation in erythrocytes. The mitochondria of the
dead cells appeared intact with regard to both ultrastructure and membrane potential. Also isolated rat
liver mitochondria were resistant to Abl, judged by their ultrastructure and lack of cytochrome c release.
The sparing of the mitochondria could be related to the low cholesterol content of their outer membrane.
In fact, a supplement of cholesterol in liposomes sensitised them to Abl. In contrast, the prokaryote-directed cy-
clic lipopeptide surfactin lysed preferentially non-cholesterol-containing membranes. In silico comparison of the
positions of relevant functional chemical structures revealed that Abl Amatched poorly with surfactin in spite of
the common cyclic lipopeptide structure. Abl A and the plant-derived glycolipid digitonin had, however, predict-
ed overlaps of functional groups, particularly in the cholesterol-binding tail of digitonin. This may suggest inde-
pendent evolution of Abl and digitonin to target eukaryotic cholesterol-containing membranes. Sub-lytic
concentrations of Abl A or B allowed inﬂux of propidium iodide into cells without interfering with their
long-term cell viability. The transient permeability increase allowed the inﬂux of enough of the cyanobacterial
cyclic peptide toxin nodularin to induce apoptosis. The anabaenolysins might therefore not only act solely as ly-
sins, but also as cofactors for the internalisation of other toxins. They represent a potent alternative to digitonin to
selectively disrupt cholesterol-containing biological membranes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Cyanobacteria represent a rich source of bioactive compounds, in-
cluding an abundance of substances containing cyclic peptides not
produced by higher eukaryotes [1]. Based on screens of aquatic
cyanobacteria for cell death inducing compounds [2,3], we isolated
two related cyclic lipopeptides (anabaenolysin A and B, Abl A and B;
Figs. 1A and S1A) from marine benthic cyanobacteria of the genera
Anabaena [4]. Their amino acid composition consists of four amino
acids from which two are proteinogenic and two unusual; glycine1,
glycine2, 2-(3-amino-5-oxytetrahydrofuran-2-yl)-2-hydroxyacetic acid3
and a long unsaturated C18 β-amino acid4 with a conjugated trieneescent protein; PI, propidium
ase extraction; TEM, transmis-
ne, University of Bergen, Jonas
81; fax: +47 55 58 63 60.
rﬁndal).
isorders, Stavanger University
l rights reserved.structure. These two amphipathic toxins are relatively compact
(MW=558 and 560), have no charge at physiological pH, and in-
duced both cell necrosis and haemolysis [4].
Lipopeptides are highly abundant in cyanobacteria, and show a
large variation in both structure and bioactivity [5]. They can cause
membrane damage, but some can also cross membranes without
disrupting them. Comparatively little is known about the amphipathic
cyanobacterial lipopeptides. Some are believed to perturb membranes
of organisms that either compete for space, nutrients and light, or
grazers feeding on the cyanobacteria [5]. Membrane-damaging biologi-
cal compounds [6] can be categorised as enzymatic, pore-forming or
detergent-like [7,8]. The detergent-like toxins, like the plant-derived
sugar-containing saponins and the bacterially derived lipopeptide
surfactin, apparently destabilise and disrupt the integrity ofmembranes
[9–11]. The amphipathic biodetergents with the highest potency, like
the glycopeptide digitonin, may bind preferentially to subdomains of
the outer membrane leaﬂet [12,13].
The present study was initiated to reveal the cellular effects by the
unusual cyanobacterial lipopeptides Abl A and B [4]. We used both
cells, and membrane models like liposomes to ﬁnd the mode of action,
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Fig. 1. Abl A causes necrotic cell death without mitochondrial damage. A: The structure of anabaenolysin A (Abl A) depicted with L-amino acids. B and C: Human NB4 leukaemia cells
were treated with 15 μMAbl A from 0.5 to 15 min and analysed for changes in (B) apparent size (forward scatter: FSC) and granularity (side scatter: SSC), and (C) inﬂux of propidium
iodide (PI) by ﬂow cytometry. D and E: IPC-81 rat leukaemia cells were incubated for 30 min without (D) or with (E) 18 μM Abl A, ﬁxed and studied by transmission electron mi-
croscopy. F: A typical mitochondrion from the cell shown in panel E. G and H: NRK cells were exposed to vehicle (G) or 9 μM Abl A (H) in the presence of mitotracker (red ﬂuores-
cence), which labels viable mitochondria with intact membrane potential. After 15 min the cells were ﬁxed with 2% buffered formaldehyde, containing the DNA stain Hoechst 33342
(blue), and studied by ﬂuorescence microscopy.
3001L. Oftedal et al. / Biochimica et Biophysica Acta 1818 (2012) 3000–3009and hypotheses were supported by in silico modelling. We show that
Abl A and B act like amphipathic biodetergents, Abl A being a more po-
tent haemolysin than digitonin. Abl A and B permeabilise liposomes in a
cholesterol-dependentmanner. They induce necrotic death ofmamma-
lian cells while sparing their mitochondria, whose membrane has low
cholesterol content. The anabaenolysins appear therefore to be targeted
against eukaryotic membranes, in distinction to the bacterial lipopeptide
surfactin, which shows preference for the non-cholesterol containing
membranes found in prokaryotes.2. Materials and methods
2.1. Materials
Pure anabaenolysin A and B were isolated as recently described [4].
Hoechst 33342, surfactin, digitonin, cholesterol, acetonitrile (Rathburn),
propidium iodide (PI) and calcein were from Sigma-Aldrich, St. Louis,
USA. Dulbecco's modiﬁed Eagle medium (DMEM), foetal calf serum
and horse serum were supplied by EuroClone® Life Sciences Division,
3002 L. Oftedal et al. / Biochimica et Biophysica Acta 1818 (2012) 3000–3009Milano, Italy. RPMI 1640 Medium (Gibco) was from Invitrogen AS,
Carlsbad, USA. Complete protease inhibitor cocktail tablets were from
Roche Diagnostics, Mannheim, Germany. Osmium tetroxide and agar-
100 resin were supplied by EMS, Hatﬁeld, USA. Cytochrome c antibody
(H-104) was from Santa Cruz, San Diego, USA. CDP®Star was from
Tropix, Bedford, USA. Phosphatidylcholine isolate (95% PC, Emulmetik
930) was from Lucas Meyer cosmetics, Champlan, France, and hydroge-
nated egg phosphatidylcholine was from Lipoid AG (Steinhausen,
Switzerland). All other chemicals were from VWR (West Chester, USA)
and of analytical grade.
2.2. Maintenance of cell lines and experimental conditions
IPC-81 rat promyelocytic leukaemia cells [14] were cultured in
Dulbecco's modiﬁed Eagle's medium with 10% (v/v) heat inactivated
horse serum. Human NB4 promyelocytic leukaemia cells [15] were cul-
tured in RPMI 1640 medium with 10% (v/v) heat inactivated foetal calf
serum. Normal rat kidney ﬁbroblasts (NRK, ATCC: CRL-6509) were
cultured in Dulbecco's modiﬁed Eagle's medium with 10% (v/v) heat
inactivated foetal calf serum. All cells were incubated at 37 °C in a
humid atmosphere of 5% CO2.
The plasmamembrane permeability of non-ﬁxed cells was assessed
by microscopic or ﬂow cytometric detection of propidium iodide (PI)
inﬂux. NB4 cell density was adjusted to 0.5×106 cells/ml before adding
anabaenolysins or solvent in the presence of 0.1% PI. At least 50,000
non-gated cell events were collected for each sample on an AccuriC6
ﬂow cytometer (BD, Accuri cytometry, MI, USA). Mitochondria of Abl
A treatedNRK cells were stainedwithMitoTracker® (Molecular Probes,
Eugene, OR) according to the manufacturer's instructions. The cells
were then ﬁxed in buffered formaldehyde and studied by ﬂuorescence
microscopy.
2.3. Scanning- and transmission electron microscopy
Transmission electronmicroscopy of Abl-treated NB4 cells or rat liver
mitochondria was done as previously described [16], and studied with a
Jeol JEM-1230 transmission electron microscope. For scanning electron
microscopy NRK cells were cultured and treated with detergents on col-
lagen coated coverslips beforeﬁxation. Fixed erythrocytes andmitochon-
dria were spun onto collagen-coated coverslips. The specimens were
washed with cacodylate buffer, post-ﬁxed for 60 min with 1% osmium
tetroxide and thereafter step-wise dehydrated in ethanol. Specimens
were examined using a Jeol JSM-7400F scanning electron microscope.
2.4. Isolation of mitochondria from primary rat hepatocytes and detection
of cytochrome c
Primary rat hepatocytes were isolated from male Wistar rats
(80–150 g) using in vitro collagenase perfusion [17], as previously de-
scribed [18]. The rat experiments were approved by the Norwegian
Animal Research Authority and conducted according to the European
Convention for the Protection of Vertebrates Used for Scientiﬁc Purposes.
Primary rat hepatocytes (6×106) were homogenised in ice-cold homog-
enisation medium (0.25 M sucrose, 2 mM Hepes, 0.2 mM EGTA, 0.1%
BSA) using a ball-bearing cell cracker (EMBL, Heidelberg, Germany). The
homogenatewas ﬁrst centrifuged 1200×g for 10 min at 4 °C. Postnuclear
supernatants were centrifuged at 12,000×g for 10 min at 4 °C and the
pellet fraction containing the mitochondria were collected and dissolved
in the mitochondrial respiration medium MiR05 (0.5 mM EGTA, 3 mM
MgCl2, 60 mM K-lactobionate, 20 mM taurine, 10 mM KH2PO4, 20 mM
Hepes, 110 mM sucrose, 1 g/l bovine serum albumin). After incubation
of isolated mitochondria with anabenolysins the mitochondria were
centrifuged 12,000×g for 10 min at 4 °C and the supernatants and the
mitochondria were collected. Proteins in supernatant or mitochondria
were lysed in 10 mM K2HPO4, 10 mM KH2PO4, 1 mM EDTA (pH 6.8)
containing 10 mM CHAPS, 50 mM NaF, 0.3 μM NaVO3 supplementedwith Complete protease inhibitor and separated using Tricine SDS-page.
Proteins were blotted onto a Hybond polyvinyldiﬂuoride membrane
(GE Healthcare, Little Chalfont, UK) and cytochrome c was visualised by
alkaline-phosphatase conjugated antibody and CDP®Star as enzyme sub-
strate. Detection was performed in a LAS-3000 Fuji Imager.
2.5. Preparation and determination of permeability of liposomes
Liposomes were prepared from soybean phosphatidylcholine (PC)
isolate or pure hydrogenated egg phosphatidyl choline (HEPC). The
PC or HEPC was dissolved in chloroform and evaporated in a rotary
evaporator. Liposomes with cholesterol were prepared by adding
cholesterol to the PC solution at molar ratio of 1.8:1 (5 mg PC and
1.2 mg cholesterol). The dry bioﬁlm was hydrated with 60 mM
calcein solution. The calcein solution was prepared by adding buffer
(10 mM Tris–HCl with 1 mM EDTA) to a 300 mM calcein solution in
1 N NaOH until pH 8 was reached. After rehydration, the liposomes
were extruded (LIPEX™ extruder; Northern lipids, Burnaby, Canada)
ten times through a 0.2 μm ﬁlter (Whatman, Kent, UK) at 20 °C. The
liposomes were transferred to a 10 mM Tris–HCl (pH 8) buffer with
100 mM NaCl and 1 mM EDTA by gel ﬁltration on a Sephadex G-50
(medium grade; Sigma-Aldrich, St. Louis, USA) column. Membrane
intactness was measured based on calcein release from the lipo-
somes. Detergents were added to diluted liposome suspension, and
the ﬂuorescence (λEX 500, λEM 517) recorded with a Cary Eclipse
ﬂuorescence spectrophotometer (Varian, Santa Clara, CA, USA). Triton
X-100 (ﬁnal concentration 0.1%) was added to determine maximum
calcein release.
2.6. Erythrocytes: isolation, experimental conditions, and measurement
of haemolysis and release of adenosine nucleosides
Human full blood in acid citrate dextrose (11 mMcitric acid, 13 mM
sodium citrate, 17 mM glucose) was centrifuged 1750×g for 7 min and
the erythrocytes collected and suspended in buffered (pH 7.4) NaCl so-
lution (9.0 g/l). In each experiment, 2×107 erythrocytes were incubat-
ed for 1 h at 20 °C with the various agents to be tested.
For determination of haemolysis the erythrocytes were centrifuged
at 300×g for 15 min at 20 °C and the absorbance of the supernatant
read at 540 nm. For determination of maximum haemolysis the eryth-
rocytes were incubated in buffered (pH 7.4) hypotonic NaCl solution
(1.0 g/l).
To measure the release of adenosine nucleotides from erythro-
cytes, the supernatant from four experiments was combined and
analysed on a Hitachi LaChrom HPLC system (VWR, West Chester,
USA), equipped with a L-7455 diode array detector. Analytes in the
supernatants were separated on a reversed phase chromatography
column, Kromasil®KR100-5-C18 (250×4.6 mm (i.d.) from EKA
chemicals, Bohus, Sweden) with a ﬂow rate of 0.8 ml/min. A 5 min
isocratic run with 0.1 M phosphate buffer, pH 7, was followed by a
10 min gradient to 70% acetonitrile. The area of the nucleotide peaks
at 256 nm was used to determine their concentration.
2.7. Molecular modelling
Pharmacophore models were prepared with the Phase module of
the Schrodinger® software (www.schrodinger.com). Low energy con-
formations of Abl A, cholesterol, digitonin and surfactin (PubMed com-
pound IDs: 5997, 409778 and 65307 respectively) tautomers at neutral
pH were generated (force ﬁeld: OPLS_2005, solvation treatment: dis-
tance dependent dielectric, max. rel. energy diff: 10 kcal/mol, RMSD of
1.0 Å), and pharmacophore siteswere deﬁnedusing the default settings
(deﬁnitions: min. intersite distance: 2.0 Å, max. tree depth: 5, initial
box size: 32 Å, ﬁnal box size: 1 Å, scoring: RMSD below 1.2 Å, vector
scores above 0.5 Å, survival score formula: vector, site, volume, and
3003L. Oftedal et al. / Biochimica et Biophysica Acta 1818 (2012) 3000–3009no. of matches all set to 1.0). The structures were then aligned based on
the pharmacophores with the highest survival score.
3. Results and discussion
3.1. Features of the anabaenolysin-induced lysis of nucleated mammalian
cells
The newly discovered [4] cyclic lipopeptide anabaenolysin A (Abl
A, Fig. 1A) was studied for effects on NB4 leukaemia cells and hepato-
cytes. We noted that higher concentration of Abl A was required to
produce cell lysis when the cell concentration was high (above 300,000
hepatocytes/ml or above 700,000 NB4 cells/ml) (not shown). All cell ex-
periments reported herewere therefore conducted at cell concentrations
where the apparent EC50 for Abl A-induced lysis was independent of cell
concentration.
NB4 cells incubated for 0.5 to 15 min with 15 μM Abl A were ﬁxed
and analysed by ﬂow cytometry. Abl A decreased the apparent cell
size (FSC) and increased the granularity (SSC; Fig. 1B) already after
0.5 min incubation. We also noted a drop in granularity at the later
time-points (Fig. 1B). Abl A caused also inﬂux of propidium iodide
(PI, Fig. 1C), which is a sign of deﬁcient surface membrane integrity.
Transmission electron microscopy revealed that the Abl A exposed
cells had lost most of their electron dense intracellular material
(Fig. 1D and E). This can explain the dramatic drop in size seen by
ﬂow cytometry (Fig. 1B), which could be caused by detection of
nuclei only. A notable exception of the lysis of the cellular compo-
nents was the mitochondria, which appeared morphologically intact
(Fig. 1F). The functional intactness of the mitochondria was probed
by incubating NRK cells with Mitotracker® after exposure to Abl A.
The mitochondria remained well stained with Mitotracker® (Fig. 1G
and H) even in cells incubated with enough Abl A to become
permeabilised to PI, but not causing massive lysis. In line with this, we
found that Abl A was equally potent against IPC-81 cells with enforced
expression of the anti-apoptotic protein Bcl-2 [19], which preventsmito-
chondrial permeability transition pore opening (Supplementary Fig. S2),
suggesting that the cell death was not coupled to typical apoptotic path-
ways involving the mitochondria.
We found that cells incubated continuously with sub-lytic (not caus-
ing membrane lysis observable by light or transmission electron micros-
copy) Abl A concentrations could show increased PI inﬂux without
microscopical or ﬂow cytometric (FSC/SSC) indices of cell death (not
shown). They had also an intact ability to undertake clathrin-dependent
endocytosis of transferrin (Supplementary Fig. S3A). Furthermore, while
leukaemia cells exposed for only 1 min to 6–8 μMAbl A had an increased
PI content, this was not true if Abl A was removed from the cells before
challenging the cells with PI. Suchwashed cells also continued to prolifer-
ate normally (not shown) suggesting that the early membrane perme-
ation caused by Abl A can be reversible. We considered therefore that
Abl might promote the internalisation of substances without killing the
cells.
We tested ﬁrst if sub-lytic concentrations of Abl A could allow the
cyanobacterial cyclic peptide toxin nodularin to be internalised and in-
duce apoptosis in cell types like NRK, which normally are impermeable
to this type of toxins and therefore depend on nodularinmicroinjection
to achieve apoptosis [20]. NRK cells treated with a combination of Abl A
and nodularin underwent apoptosis similar to that seen after nodularin
microinjection [20,21], whereas cells treated with nodularin alone
retained their normal morphology (Supplementary Fig. S4A). We con-
clude that anabaenolysin can synergisewith other cyanobacterial toxins
like nodularin to induce eukaryotic cell death.
We tested next if Abl A could enhance the cellular uptake of mac-
romolecules like the plasmid encoding green ﬂuorescent protein
(eGFP). For this purpose we used HEK293 cells, which hardly show
any “spontaneous” uptake of plasmid, as judged by the lack of GFP
positive cells (not shown). We did note, however, that a signiﬁcantproportion of the cells expressed GFP if the plasmid was given togeth-
er with a sub-lytic concentration of Abl A (Supplementary Fig. S4B).
Although the transfection was more efﬁcient with calcium phosphate
(Supplementary Fig. S4C), the data show that sub-lytic concentra-
tions of Abl A allowed not only the internalisation of plasmid into
cells, but also avoided serious cell damage, since both the transcrip-
tion and translation machinery had to be intact to produce enough
eGFP to be detected microscopically.
To knowmore about the nature of the membrane damage inﬂicted
by Abl A, we exposed NRK cells to high concentrations of Abl A as well
as to the established biodetergent toxins surfactin and digitonin.
Since Abl A appeared to cause most of it effects on membranes
(Fig. 1), we chose to study the cell surface by scanning electron mi-
croscopy (SEM). This revealed that high concentrations of Alb A
could solubilise completely the lipid component of the plasma mem-
brane (Fig. 2 C and D), exposing the perimembraneous sub-cortical
cytoskeletal web (Fig. 2 C and D). A similar morphology was observed
for cells treated with Abl B (Supplementary Fig. S1D and E), digitonin
(Fig. 2E and F), and surfactin (Fig. 2G and H), which both are known
to have a detergent-like mechanism of action [10,13].
3.2. The haemolytic effect of anabaenolysins. Comparison with surfactin
and digitonin
The single bilayer membrane of the red blood cell serves as model
for eukaryotic cell membranes [22]. The haemolytic potency of Abl A
was about 5 times higher than for digitonin and about 50-fold higher
than for surfactin (Fig. 3G). It is also more than one order of magni-
tude higher than what has been reported for dirhamnolipids [23],
and trehalose lipids [24].
We tested also if inhibitors directed against speciﬁc processes in-
criminated in erythrocyte lysis could interfere with Abl-induced
haemolysis. We found that none of these inhibitors could antagonize
the Abl A or Abl B-induced haemolysis (Supplementary Fig. S5). We
considered therefore if the amphipathic anabaenolysins could act as
membrane perturbing detergents and insert into the membranes.
Many detergents induce either discocyte–echinocyte erythrocyte
transformation or discocyte–stomatocyte transformation with forma-
tion of endocytic vesicles, depending on whether the detergent
targets the positively curved (outer leaﬂet) or negatively curved
(inner leaﬂet) of the erythrocyte membrane [25,26]. We found that
the haemolysis caused by Abl A and B was accompanied by discocyte–
echinocyte transformation (Fig. 3). The haemolysis induced by Abl A
or Bwas coupledwith release of adenine nucleotides (Fig. 3G). A similar
coupling was noted for the detergents digitonin and surfactin (Fig. 3G).
The discocyte–echinocyte transformation, together with a simulta-
neous release of haemoglobin and adenine nucleotides is typical for am-
phipathic detergents inserting into the outer membrane leaﬂet of
erythrocytes [25–27]. In contrast, dirhamnolipid and trehalose lipid
biosurfactants causes a mixed spherocyte/echinocyte morphology,
suggested to be due to insertion into the outer membrane leaﬂet
(echinocytosis), but also some osmotic lysis (spherocytosis) [23,24].
3.3. Anabaenolysins do not permeabilise isolated mitochondria and show
cholesterol-dependent permeabilisation of liposomes
Although the anabaenolysins efﬁciently lyse the membranes of
both nucleated (Figs. 1 and 2) and anucleated cells (Fig. 3), the mito-
chondria appeared functional (Fig. 1G and H). Further evidence for
the mitochondrial resistance to Abl A was obtained by incubating iso-
lated rat liver mitochondria with Abl A at concentrations above those
required to induce complete cell lysis. The toxin had no visible effect
on the shape, surface membrane or the internal membrane organisa-
tion of the mitochondria, (Fig. 4A–D). Neither did we observe any
leakage of cytochrome c (Fig. 4E), which is an early marker of mito-
chondrial pore formation associated with apoptosis [28].
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Fig. 2. The surface morphology of NRK cells exposed to Abl A, surfactin or digitonin. NRK cells were treated with vehicle (A and B), 15 μM Abl A (C and D), 20 μM digitonin (E and F)
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3004 L. Oftedal et al. / Biochimica et Biophysica Acta 1818 (2012) 3000–3009The outer mitochondrial membrane contains only about 5% cho-
lesterol, whereas the cellular surface membranes contain about 30%
[29]. We noted also that erythrocytes when partially depleted of cho-
lesterol by cyclodextrin pre-incubation [30] became more resistant to
Abl A and digitonin, but less resistant to surfactin (data not shown).
These observations suggest that the anabaenolysins could depend at
least in part on the cholesterol component of the membrane for
their perturbing action. To test this more rigorously we compared
the ability of Abl A and B to induce release of ﬂuorescent calcein
from liposomes composed of phosphatidylcholine with or without
cholesterol. Both Alb A (Fig. 5 A and B) and Alb B (SupplementaryFig. S1) were more potent disruptors of liposomes containing choles-
terol. The 5% cholesterol present in the mitochondrial membrane ap-
pears to be insufﬁcient for Abl A to cause membrane permeabilisation
(Fig. 4E). Interestingly, Abl-Ahad equal activity against liposomesmade
from soy phosphatidylcholine (Fig. 5A and B) and liposomesmade from
hydrogenated phosphatidylcholine (data not shown), both with and
without cholesterol. This suggests that Abl A has a high ability to insert
between the acyl-chains and cholesterol in the hydrophobic core of the
membranes.
As expected [9] the plant-derived biodetergent digitonin also
had a preference for cholesterol-containing membranes, even more
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like Abl is a cyclic lipopeptide, lysed preferentially cholesterol-free lipo-
somes (Fig. 5E and F). The behaviour of Abl A, Abl B and digitonin is in
contrast to biodetergents like surfactin [31], dirhamnolipids [23], and
trehalose lipids [32], which preferentially lyse membranes that do not
contain cholesterol. The preference for membranes not containing
cholesterol may explain why surfactin has been promoted as an
anti-bacterial/anti-fouling agent [31], since prokaryotic membranes
lack cholesterol [29].
We next compared in silico the pharmacophore sites of Abl A with
those of digitonin and surfactin.We noted high-survival pharmacophore
constellations matching both Abl A and digitonin (Fig. 6A and B). This
suggests that Abl A anddigitoninmay bind similarly tomolecular targets,
like membrane components. When the Phase module of Schrödinger™
was set to align Abl A, digitonin and cholesterol we noted again a close
overlap of high-survival pharmacophore constellations (Fig. 6C). A
close association was noted for both the hydrophobic and electrophilic
centres between cholesterol and the known cholesterol-binding digito-
nin [9]. The similar association for Abl A is compatible with, although
not proof of, similar cholesterol binding ability also for Abl.When set to align Abl A and surfactin based on common
pharmacophores, the Phase module of Schrödinger™ was unable to
obtain any extensive high survival alignment. One obvious difference
is the presence of two charged carboxyl moieties in surfactin against
no charged residues in Abl. This difference may have functional signiﬁ-
cance, sincewe noted a signiﬁcant drop in activity of Abl A towards both
cells and cholesterol-containing liposomes when the lactone-moiety of
Abl A or B was hydrolysed, creating a carboxy-group (not shown). Pos-
sibly, the charged moieties resist the partial insertion of the polar head
molecules into the membrane [33]. We noted also poor overlap be-
tween the hydrophobic tails of surfactin and Abl A (Supplementary
Fig. S6). This may be related to the shorter length of the hydrocarbon
chain of surfactin (11 carbon atoms as compared to 15 carbon atoms
in Abl A and B; [4]).
We conclude that the potency of Abl A to lyse cholesterol-
containing membranes rivals that of digitonin in potency and selec-
tivity between mammalian cell surface and mitochondrial mem-
branes. In spite of their dissimilar origin and chemical composition
Abl A and digitonin share a number of crucial pharmacophore sites,
suggesting at least partially common molecular targets.
Cyt c Sup Pellet
Control Anabaenolysin A
18 µM 9 µM
Supernatant Pellet
0.5µM
0.5µM
A B
C D
E
Untreated Anabaenolysin A
18 µM 9 µM
Fig. 4. Abl A does not permeabilise the membrane of isolated mitochondria. A–D: Mitochondria were isolated from primary hepatocytes, incubated with vehicle (A and C) or 18 μM
Abl A (B and D) for 1 h, ﬁxed and processed for scanning (A and B) or transmission (C and D) electron microscopy. E: The isolated mitochondria were incubated with vehicle, 18 or
9 μM Abl A for 1 h, and the supernatant and mitochondrial pellet separated. The mitochondrial pellet and supernatant were next subjected to SDS electrophoresis and immuno-
blotting with anti‐cytochrome c antibody. Pure cytochrome c was included as standard. Note that Abl A failed to cause either morphological changes of, or release of cytochrome
c from the mitochondria.
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The novel cyclic lipopeptides Abl A and B (Figs. 1A and S1A; [4])
caused haemolysis at a lower concentration than previously de-
scribed biodetergents (Fig. 3), like the plant saponin digitonin and
the B. subtilis‐derived cyclic lipopeptide surfactin [34]. Both digitonin
and surfactin have unusual low lytic concentration compared to many
synthetic detergents [13,35], which act as general membrane
perturbants [36]. The higher lytic potency of biodetergents has been
ascribed to heterogeneous membrane perturbation, with the creation
of local membrane defects that leave most of the membrane unaffect-
ed [36]. The high potency of Abl A and B suggests strongly that they
also target membrane subdomains. Abl A and B resemble several
other biodetergents by inducing discocyte–echinocyte erythrocyte
transformation (Fig. 3), and by solubilising the lipid component of
the surface membrane (Fig. 2). The anabaenolysins appear therefore
to be new and highly potent members of the biodetergent family.
Abl A and B and surfactin share a polar cyclic peptide head and a
hydrophobic hydrocarbon chain, but still differed strikingly with
regard to membrane selectivity. While Abl A and B preferentially
destabilise cholesterol-containing membranes, surfactin preferentiallylyses cholesterol-free liposomes (Fig. 5). Both Abl A and B lack charged
residues in their polar head (Figs. 1 and 6, and Supplementary Figs. S1
and S6),while surfactin has two carboxyl-moieties and a shorter hydro-
phobic tail than Abl A and B. These features will combine to counteract
any deep insertion of surfactin into the hydrophobic interior of thick
biomembranes. In line with this, we noted that biodetergents with a
sugar-based polar head differ in activity based on charge. Digitonin is
uncharged at physiological pH, whereas rhamnolipids and trehalose
lipids both are negatively charged at physiological pH [23,32]. It thus
appears that a neutral polar head causes cholesterol dependency,
whereas a negative charge inverts the cholesterol dependency
(Fig. 5E and F) [23,32]. In line with this, we noted a marked drop
in Abl A activity if the lactone-bond was hydrolysed to form a
carboxy moiety (not shown). Another distinguishing feature of the hy-
drophobic tails is the lack of double bonds in surfactin.
The double bonds of Abl A serve to allow its hydrophobic tail to align
well with either digitonin or cholesterol (Fig. 6). Digitonin binds choles-
terol and related steroids [9,37]. The presence of a hydrogen-bond accep-
tor (cholesterol, Fig. 6C, red sphere) and donor (Abl A and digitonin,
Fig. 6A, blue sphere) together with the hydrophobic centres (green
spheres) is in line with the observed binding of cholesterol to digitonin
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Fig. 5. Abl A permeabilises preferentially cholesterol-containing liposomes. Phosphatidylcholine liposomes without (A, C and E) or with (B, D and F) cholesterol containing the ﬂuo-
rescent marker calcein were incubated with the given concentrations of Abl A (A and B), digitonin (C and D) or surfactin (E and F) for 9 min before Triton X-100 (0.1% ﬁnal
concentration) was added (arrow) to achieve maximum calcein release. See the Materials and methods section for details on liposome preparation and experimental conditions.
Note that Abl A was more potent against the cholesterol-containing liposomes (A) than either digitonin (D) or surfactin (F), and that Abl A, like digitonin, but opposite to surfactin,
induced permeabilisation of liposomes in a cholesterol-dependent manner.
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contribute to the observed cholesterol-dependence of the Abl lytic ac-
tion. Another option is that Abl A inserts into membranes, but instead
of binding to cholesterol, unfavourable interactions causes repulsion
leading to segregation of the membrane components. This has been
suggested to be the case for surfactin-mediated destabilisation of mem-
branes [38], but in this case repulsion was between negatively charged
lipids and the negative polar head of surfactin. Although there is a high
degree of similarity between digitonin and Abl A (Fig. 6C), suggesting
that favourable interactions between cholesterol and Abl A represent
the major cause of membrane destabilisation, as is the case with
digitonin [9,37], we cannot exclude that repulsing forces destabilise
cholesterol-containing membranes.
Cyanobacterial non-ribosomal cyclic peptides appeared early in evo-
lution [39], and their purpose at the time of origin is still unknown. Someof themmay have undergone modiﬁcations to selectively target grazers
such as zooplankton, like the phosphatase inhibitors microcystins and
nodularin [40], protease inhibitors [41], and inhibitors of cellular trans-
port of small metabolites [42,43]. The anabaenolysins may represent
another prokaryote-derived eukaryote-directed toxin, since they target
cholesterol-containing membranes, typically found in eukaryotes.
The observation that Abl A at sublytic concentrations enhanced
the uptake/apoptotic effect of the cyanobacterial toxin nodularin
against mammalian NRK cells (Fig. S3) suggests that a possible
side-function of Abl is to enhance the penetration of other sub-
stances. It should be noted that nodularin and microcystin do not
penetrate most cell membranes even when their charged moieties
are neutralised [20].
In conclusion, the anabaenolysins target cellular membranes
containing cholesterol. Their high potency makes them suited for
Fig. 6. Abl A shares structural and functional moieties with digitonin and cholesterol. Low energy conformations of Abl A, digitonin and cholesterol tautomers at neutral pH were gener-
ated and pharmacophore sites were deﬁned using the Phasemodule of the Schrodinger™ software (www.schrodinger.com). A and B: Alignment of Abl A (magenta) and digitonin (blue)
based on the highest scored pharmacophore constellation. A: Tube representation, the right panel is rotated 90° clockwise along the z-axis. B: As in A, but with surface representation
(grid). C: Alignment of Abl A, digitonin and cholesterol based on the highest scored pharmacophore constellation. Colours as in A, cholesterol is in orange.
3008 L. Oftedal et al. / Biochimica et Biophysica Acta 1818 (2012) 3000–3009selective lysis of surface and non-mitochondrial organelle mem-
branes. They should also be considered for future studies aiming for
the selective perturbations of membrane subdomains or the selective
solubilisation of subsets of membrane constituents.Acknowledgements
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